MONTRÉAL, Feb. 26, 2019 /CNW Telbec/ - Oligo Medic announced that Alberto Restrepo has joined the company in the position of Chief Medical Officer to develop medical affairs related to its first product JointRep™.
"This is the kind of product which uses an approach we have been waiting for in cartilage repair - an effective single step procedure, using a bioscaffolding system based on a well-appreciated biomaterial, designed and delivered with the utmost ease of handling in mind for confident use by the surgeon and with minimal procedural risk for the patient", says Dr. Restrepo. He brings the company invaluable expertise garnered through his long career as an orthopedic surgeon and central role in the clinical development of BST-CarGel®.
Dr. Restrepo is an orthopaedic surgeon who after more than 20 years of a successful career as an arthroscopic surgeon and academic, was appointed in October 2005 by the company called BioSyntech to set up and manage the Medical Affairs of the company. He contributed with his medical expertise and management skills to the success of the project BST-CarGel® on cartilage repair. After its acquisition by Piramal Life Sciences, he managed both the clinical and medical departments. He was part of the reduced management team who successfully obtained the CE Mark, Canadian, Australian as well as other countries approval for the chitosan based product BST-CarGel®, as well as its reimbursement in several countries. He had a pivotal role in the two Level 1 successful RCTs for cartilage repair with BST-CarGel®. He set up the medical networking for its commercialization in Europe, Canada, LATAM, India and Australia/New Zealand, and participated actively in the team which designed the marketing and training strategies to introduce the technology worldwide.
About Oligo Medic
Oligo Medic is a biomaterials company focusing on developing and commercializing medical devices for minimally-invasive tissue repair procedures. The company's leading product JointRep™ is a paradigm-shifting solution indicated for the treatment of articular cartilage. For more information, you can visit www.oligomedic.com.
SOURCE Oligo Medic inc.
For further information: Oligo Medic Inc., firstname.lastname@example.org